메뉴 건너뛰기




Volumn 28, Issue 2, 2009, Pages 167-172

Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors

Author keywords

Conversion; TNF inhibitors; Tuberculin

Indexed keywords

BCG VACCINE; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

EID: 58149195298     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-008-1007-9     Document Type: Article
Times cited : (27)

References (21)
  • 1
    • 34250656516 scopus 로고    scopus 로고
    • Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection
    • Gomez-Reino J, Carmona L, Descalzo M (2007) Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum 57:756-761
    • (2007) Arthritis Rheum , vol.57 , pp. 756-761
    • Gomez-Reino, J.1    Carmona, L.2    Descalzo, M.3
  • 2
    • 0033559125 scopus 로고    scopus 로고
    • Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection which is not compensated for by lymphotoxin
    • Bean AG, Roach DR, Briscoe H et al (1999) Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection which is not compensated for by lymphotoxin. J Immunol 162:3504-3511
    • (1999) J Immunol , vol.162 , pp. 3504-3511
    • Bean, A.G.1    Roach, D.R.2    Briscoe, H.3
  • 3
    • 0028979703 scopus 로고
    • Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice
    • Flynn JL, Goldstein MM, Chan J et al (1995) Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-572
    • (1995) Immunity , vol.2 , pp. 561-572
    • Flynn, J.L.1    Goldstein, M.M.2    Chan, J.3
  • 4
    • 0035846326 scopus 로고    scopus 로고
    • Tuberculosis associated with infliximab, a tumor necrosis factor-α-neutralizing agent
    • Keane J (2001) Tuberculosis associated with infliximab, a tumor necrosis factor-α-neutralizing agent. N Engl J Med 345:1098-1104
    • (2001) N Engl J Med , vol.345 , pp. 1098-1104
    • Keane, J.1
  • 5
    • 33646269274 scopus 로고    scopus 로고
    • Does anti-tumour necrosis factor a treatment modify the tuberculin PPD response?
    • Joven BE, Almodovar R, Galindo M, Mateo I, Pablos JL (2006) Does anti-tumour necrosis factor a treatment modify the tuberculin PPD response? Ann Rheum Dis 65:699
    • (2006) Ann Rheum Dis , vol.65 , pp. 699
    • Joven, B.E.1    Almodovar, R.2    Galindo, M.3    Mateo, I.4    Pablos, J.L.5
  • 6
    • 0032902382 scopus 로고    scopus 로고
    • Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion
    • Menzies D (1999) Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 159:15-21
    • (1999) Am J Respir Crit Care Med , vol.159 , pp. 15-21
    • Menzies, D.1
  • 7
    • 23944526078 scopus 로고    scopus 로고
    • Attenuated response to purified protein derivative in patients with rheumatoid arthritis: Study in a population with a high prevalence of tuberculosis
    • Ponce de Leon D, Acevedo-Vasquez E, Sanchez-Torres A et al (2005) Attenuated response to purified protein derivative in patients with rheumatoid arthritis: Study in a population with a high prevalence of tuberculosis. Ann Rheum Dis 64:1360-1361
    • (2005) Ann Rheum Dis , vol.64 , pp. 1360-1361
    • Ponce de Leon, D.1    Acevedo-Vasquez, E.2    Sanchez-Torres, A.3
  • 9
    • 34547411842 scopus 로고    scopus 로고
    • Tuberculosis among patients treated with TNF-alpha blockers
    • Fuchs-Polishuk I, Avnon LS, Abu shakra M (2007) Tuberculosis among patients treated with TNF-alpha blockers. Harefuah 146:212-218
    • (2007) Harefuah , vol.146 , pp. 212-218
    • Fuchs-Polishuk, I.1    Avnon, L.S.2    Abu shakra, M.3
  • 10
    • 34547456898 scopus 로고    scopus 로고
    • Guidelines of the Israeli association of rheumatology for prevention of tuberculosis in patients treated with TNF-alpha blockers
    • Elkayam O, Balbir-gurman A, Lidgi M, Rahav G, Weiler-Ravel D (2007) Guidelines of the Israeli association of rheumatology for prevention of tuberculosis in patients treated with TNF-alpha blockers. Harefuah 146:235-237
    • (2007) Harefuah , vol.146 , pp. 235-237
    • Elkayam, O.1    Balbir-gurman, A.2    Lidgi, M.3    Rahav, G.4    Weiler-Ravel, D.5
  • 11
    • 0033769714 scopus 로고    scopus 로고
    • Does size matter? Utility of size of tuberculin reactions for the diagnosis of mycobacterial disease
    • Al Zahrani K, Al Jahdali H, Menzies D (2000) Does size matter? Utility of size of tuberculin reactions for the diagnosis of mycobacterial disease. Am J Respir Crit Care Med 162:1419-1422
    • (2000) Am J Respir Crit Care Med , vol.162 , pp. 1419-1422
    • Al Zahrani, K.1    Al Jahdali, H.2    Menzies, D.3
  • 12
    • 1842479974 scopus 로고    scopus 로고
    • High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy
    • Mow SW, Abreu-martin MT (2004) High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy. Clin Gastroenterol and Hepatol 2:309-313
    • (2004) Clin Gastroenterol and Hepatol , vol.2 , pp. 309-313
    • Mow, S.W.1    Abreu-martin, M.T.2
  • 13
    • 0036727143 scopus 로고    scopus 로고
    • A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurement
    • Wang L, Turner MO, Elwood RK et al (2002) A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurement. Thorax 57:804-809
    • (2002) Thorax , vol.57 , pp. 804-809
    • Wang, L.1    Turner, M.O.2    Elwood, R.K.3
  • 14
    • 0034091974 scopus 로고    scopus 로고
    • Targeted tuberculin testing and treatment of latent tuberculosis infection
    • American Thoracic Society
    • American Thoracic Society (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Resp Crit Care Med 161:S221-247
    • (2000) Am J Resp Crit Care Med , vol.161
  • 15
    • 0035136526 scopus 로고    scopus 로고
    • Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors
    • Berg L, Lampa J, Rogberg S, van Vollenhoven R, Klareskog L (2001) Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors. Ann Rheum Dis 60:133-139
    • (2001) Ann Rheum Dis , vol.60 , pp. 133-139
    • Berg, L.1    Lampa, J.2    Rogberg, S.3    van Vollenhoven, R.4    Klareskog, L.5
  • 16
    • 0344628734 scopus 로고    scopus 로고
    • High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfalazine and anti-tumour necrosis factor inhibitors
    • Vanhoof J, Landewe S, Van Wijngaerden Geusens P (2003) High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfalazine and anti-tumour necrosis factor inhibitors. Ann Rheum Dis 62:1241-1242
    • (2003) Ann Rheum Dis , vol.62 , pp. 1241-1242
    • Vanhoof, J.1    Landewe, S.2    Van Wijngaerden Geusens, P.3
  • 17
  • 18
    • 33644643266 scopus 로고    scopus 로고
    • Guidelines or using the QuantiFERON-TB test for detecting Mycobacterium tuberculosis infection, United States
    • Mazurek G, Jereb J, Lobue P, Iademerco M, Metchock B, Vernon A (2005) Guidelines or using the QuantiFERON-TB test for detecting Mycobacterium tuberculosis infection, United States. MMWR Morb mortal Wkly Recomm Rep 54(RR15):49-55
    • (2005) MMWR Morb Mortal Wkly Recomm Rep , vol.54 , Issue.RR15 , pp. 49-55
    • Mazurek, G.1    Jereb, J.2    Lobue, P.3    Iademerco, M.4    Metchock, B.5    Vernon, A.6
  • 19
    • 33646026410 scopus 로고    scopus 로고
    • Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: A prospective study
    • Ferrara G, Losi M, D'Amico R et al (2006) Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: A prospective study. Lancet 367:1328-1334
    • (2006) Lancet , vol.367 , pp. 1328-1334
    • Ferrara, G.1    Losi, M.2    D'Amico, R.3
  • 20
    • 34447302542 scopus 로고    scopus 로고
    • Use of QuantiFERON TB Gold test as part of a screening program in patients with RA under consideration for treatment with anti-TNF-alpha agents: The Newcastle experience
    • Pratt A, Nicholl K, Kay L (2007) Use of QuantiFERON TB Gold test as part of a screening program in patients with RA under consideration for treatment with anti-TNF-alpha agents: The Newcastle experience. Rheumatology 46:1035-1036
    • (2007) Rheumatology , vol.46 , pp. 1035-1036
    • Pratt, A.1    Nicholl, K.2    Kay, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.